Suppr超能文献

达菲抗原在K562细胞中的表达。证明其为人类红细胞趋化因子受体。

Expression of the Duffy antigen in K562 cells. Evidence that it is the human erythrocyte chemokine receptor.

作者信息

Chaudhuri A, Zbrzezna V, Polyakova J, Pogo A O, Hesselgesser J, Horuk R

机构信息

New York Blood Center, New York 10021.

出版信息

J Biol Chem. 1994 Mar 18;269(11):7835-8.

PMID:8132497
Abstract

The human malarial parasite Plasmodium vivax invades erythrocytes by binding to a cell surface protein identified as the Duffy blood group antigen. The molecular properties of the Duffy antigen, which was recently cloned, are very similar to those of a chemokine binding protein known as the human erythrocyte chemokine receptor. This has led to the suggestion that these two molecules are the same protein. To further investigate the suspected double identity of the Duffy antigen we have transfected it into a human erythroleukemic cell line, K562. Cells stably expressing the Duffy antigen were isolated and used to characterize the protein. K562 cells transfected with the Duffy antigen displayed specific 125I-melanoma growth-stimulating activity (MGSA) binding while mock transfected cells did not. Comparison of 125I-MGSA binding to the Duffy antigen and the human erythrocyte chemokine receptor showed that the specific 125I-MGSA binding to both proteins was displaced by excess unlabeled MGSA, interleukin-8, RANTES, monocyte chemotactic peptide-1, and platelet factor 4, but not by macrophage inflammatory protein-1 alpha or -1 beta. Scatchard analysis of competition binding studies with these unlabeled chemokines revealed high affinity binding to the Duffy antigen with KD binding values of 24 +/- 4.9, 20 +/- 4.7, 41.9 +/- 12.8, and 33.9 +/- 7 nM for MGSA, interleukin-8, RANTES, and monocyte chemotactic peptide-1, respectively. A monoclonal antibody, Fy6, to the Duffy antigen inhibited 125I-MGSA binding to K562 cells expressing the Duffy antigen. Cell membranes from K562 cells permanently expressing the Duffy antigen were chemically cross-linked with 125I-MGSA. SDS-polyacrylamide gel electrophoresis analysis of the cross-linked products showed covalent incorporation of radiolabeled MGSA into a protein of molecular mass 47 kDa, and cross-linking was inhibited in the presence of unlabeled MGSA. These studies provide evidence that the Duffy blood group antigen is the same protein as the human erythrocyte chemokine receptor.

摘要

人类疟原虫间日疟原虫通过与一种被鉴定为达菲血型抗原的细胞表面蛋白结合来侵入红细胞。最近克隆的达菲抗原的分子特性与一种被称为人类红细胞趋化因子受体的趋化因子结合蛋白非常相似。这导致有人提出这两种分子是同一种蛋白。为了进一步研究达菲抗原可疑的双重身份,我们将其转染到一种人类红白血病细胞系K562中。分离出稳定表达达菲抗原的细胞并用于该蛋白的特性分析。用达菲抗原转染的K562细胞显示出特异性的125I-黑色素瘤生长刺激活性(MGSA)结合,而 mock 转染的细胞则没有。对达菲抗原和人类红细胞趋化因子受体的125I-MGSA结合进行比较表明,过量未标记的MGSA、白细胞介素-8、RANTES、单核细胞趋化肽-1和血小板因子4可取代与这两种蛋白的特异性125I-MGSA结合,但巨噬细胞炎性蛋白-1α或-1β则不能。用这些未标记的趋化因子进行竞争结合研究的Scatchard分析显示,与达菲抗原的高亲和力结合,MGSA、白细胞介素-8、RANTES和单核细胞趋化肽-1的KD结合值分别为24±4.9、20±4.7、41.9±12.8和33.9±7 nM。一种针对达菲抗原的单克隆抗体Fy6可抑制125I-MGSA与表达达菲抗原的K562细胞的结合。用125I-MGSA对永久表达达菲抗原的K562细胞膜进行化学交联。交联产物的SDS-聚丙烯酰胺凝胶电泳分析显示,放射性标记的MGSA共价掺入到一种分子量为47 kDa的蛋白中,并且在未标记的MGSA存在下交联受到抑制。这些研究提供了证据表明达菲血型抗原与人类红细胞趋化因子受体是同一种蛋白。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验